Abstract Presentations: Melanoma

Moderator(s)

• 

  Joshua Mammen, MD, PhD

  Surgical Oncologist
  University of Nebraska Medical Center
  Omaha, Nebraska, United States
• 

  Eleanor Fallon, MD

  Assistant Professor, Surgical Oncology
  Roswell Park Comprehensive Cancer Center
  Buffalo, New York, United States

Presentations:

• 1:57 PM - 2:04 PM MST

  P37. Beyond BMI: Association of Artificial Intelligence-Derived CT Body Composition with Survival in Melanoma Treated with BRAF/MEK Inhibitors
  

  Co-Author: Katherine Byrnes, BS – University of Virginia

  Co-Author: Jayasuriya Senthilvelan, BS (he/him/his) – University of Virginia

  Co-Author: Zoe Hemmer, BS – University of Virginia

  Co-Author: Jacob Sellers, BS – University of Virginia

  Co-Author: Lynn T. Dengel, MD – University of Virginia

  Co-Author: Craig L. Slingluff, Jr., MD (he/him/his) – University of Virginia

  Co-Author: Russell G. Witt, MD, MAS – University of Virginia

  Primary Presenter: Mackenzie M. Mayhew, MD (she/her/hers) – University of Virginia
• 2:04 PM - 2:11 PM MST

  P38. Impact of vaccine adjuvants on immune activation at the vaccine site after melanoma helper peptide vaccination
  

  Co-Author: Gina R. Petroni, PhD – University of Virginia

  Co-Author: Kelly T. Smith, BS – University of Virginia

  Co-Author: Marya E. Dunlap-Brown, MS – University of Virginia

  Co-Author: Ileana S. Mauldin, PhD – University of Virginia

  Co-Author: Stefan Bekiranov, PhD – University of Virginia

  Co-Author: Brian Gastman, MD – Iovance Biotherapeutics

  Co-Author: James M. Isaacs, MD – Cleveland Clinic

  Co-Author: Thach-Giao Truong, MD – Cleveland Clinic

  Co-Author: Andrew S. Poklepovic, MD – Virginia Commonwealth University

  Co-Author: Timothy N.J. Bullock, PhD – University of Virginia

  Co-Author: Craig L. Slingluff, Jr., MD (he/him/his) – University of Virginia

  Primary Presenter: Emily K. Ninmer, MD – University of Virginia
• 2:11 PM - 2:18 PM MST

  P39. A Randomized Controlled Trial Comparing Inguinal to Ilio-inguinal Lymphadenectomy for Inguinal Metastatic Melanoma with Negative Pelvic Nodes on PET / CT Scan (The EAGLE FM Study): Final Results
  

  Co-Author: Robyn Saw, MBBS, MS, FRACS – Melanoma Institute of Australia

  Co-Author: Joao Duprat, PhD (he/him/his) – A. C. Camargo cANCER cENTER

  Co-Author: Vinicius Vazquez, MD, PhD – Barretos Cancer Hospital

  Co-Author: Marc D. Moncrieff, MD PhD FRCS(Plast.) (he/him/his) – Norfolk & Norwich University Hospital

  Co-Author: Jenny Geh, BM BS – Guy's, King's and St Thomas' NHS trust

  Co-Author: John Spillane, MB BS – Peter MacCallum Cancer Centre

  Co-Author: Chris Allan, MBBS MPhil – Mater Hospital

  Co-Author: Rebecca Read, Bsc (Hons), MBBS, DPhil (she/her/hers) – The Canberra Hospital

  Co-Author: Hans De Wilt, MD, PhD – Radboud University Medical Center

  Co-Author: Marco Rastrelli, MD – Veneto Institute of Oncology

  Co-Author: Barbara L. van Leeuwen, MD, PhD – University Medical Center Groningen

  Co-Author: Julie Howell, MB BS – Westmead Hospital

  Co-Author: Rowan Pritchard Jones, MD – St Helens and Knowsley NHS Trust

  Co-Author: Terrence Wong, BSc/BBiomedSc – Melanoma Institute Australia, University of Sydney

  Co-Author: Katja Loewe, MSc – Melanoma and Skin Cancer Trials

  Co-Author: Marko Hocevar, MD, PhD (he/him/his) – Institute of Oncology, Ljubljana, Slovenia

  Primary Presenter: Andrew J. Spillane, MD BMBS B Med Sci FRACS (he/him/his) – Melanoma Institute Australia, University of Sydney
• 2:18 PM - 2:25 PM MST

  P40. Receipt of adjuvant checkpoint inhibitor therapy for melanoma and risk of subsequent skin cancer
  

  Co-Author: Joshua S. Richman, MD, PhD – University of Alabama at Birmingham

  Co-Author: Tiffany Libtow, MS – University of Michigan

  Co-Author: Tasha M. Hughes, MD, FACS (she/her/hers) – University of Michigan

  Co-Author: Christina V. Angeles, MD, FACS, FSSO (she/her/hers) – University of Michigan

  Co-Author: Michelle M. Dugan, MD – University of Florida

  Co-Author: Caitlyn N. Balsay-Patel, MD – Moffitt Cancer Center

  Co-Author: Jonathan S. Zager, MD, FACS – Moffitt Cancer Center

  Co-Author: Alexander C.J van Akkooi, MD, PhD, MSc, FRACS (he/him/his) – Melanoma Institute of Australia

  Co-Author: Robyn Saw, MBBS, MS, FRACS – Melanoma Institute of Australia

  Co-Author: Alexander Menzies, MBBS, PhD, FRACP – Melanoma Institute of Australia

  Co-Author: Georgina V. Long, AO, MBBS, PhD, MBBS, FRACP – Melanoma Institute of Australia

  Co-Author: Ian Garbarine, MD (he/him/his) – Ohio State University

  Co-Author: Erin E. Burke, MD, MS, FACS – The Ohio State University

  Co-Author: Jan Mattsson, MD, PhD – University of Gothenburg

  Co-Author: Anne Huibers, MD, PhD – University of Gothenburg

  Co-Author: Lisa Kottschade, APRN, CNP – Mayo Clinic -Rochester

  Co-Author: Tina J. Hieken, MD, FACS – Mayo Clinic -Rochester

  Co-Author: Gary C. Doolittle, MD – University of Kansas Medical Center

  Co-Author: Luke V. Selby, MD MS FACS FSSO – University of Kansas Medical Center

  Co-Author: Conor Donnelly, MD (he/him/his) – NYU Langone Health

  Co-Author: Ann Y. Lee, MD, FACS (she/her/hers) – NYU Langone Health

  Co-Author: Gray Peery, BS – University of North Carolina

  Co-Author: David W. Ollila, MD, FACS (he/him/his) – University of North Carolina School of Medicine

  Co-Author: Kaiya Kozuma, BS – Oregon Health & Science University

  Co-Author: John T. Vetto, MD, FACS, FSSO – Oregon Health & Science University

  Co-Author: Hannah G. McDonald, MD – University of Kentucky

  Co-Author: Leah K. Winer, MD – University of Kentucky

  Co-Author: Chelsea R. Olson, MD – The University of Tennessee Health Science Center

  Co-Author: Martin D. Fleming, MD, FACS (he/him/his) – University of Tennessee Health Science Center

  Co-Author: Julia Geaghan-Breiner, BS – University of Vermont

  Co-Author: Jessica A. Cintolo-Gonzalez, MD, FACS – University of Vermont

  Co-Author: Margaret O'Connor, MD, PhD – Duke University

  Co-Author: Georgia M. Beasley, MD, MHSc, FACS (she/her/hers) – Duke University

  Co-Author: Bethel Ozed-Williams, MD – University of Minnesota

  Co-Author: Jane Yuet Ching Hui, MD, MS, FACS – University of Minnesota

  Co-Author: Jennifer Hwang, MD – Fox Chase Cancer Center

  Co-Author: Jeffrey M. Farma, MD, FACS (he/him/his) – Fox Chase Cancer Center

  Co-Author: Kristy K. Broman, MD, MPH, FACS (she/her/hers) – University of Texas MD Anderson Cancer Center

  Primary Presenter: Nicole Rademacher, MD (she/her/hers) – University of Alabama at Birmingham
• 2:25 PM - 2:32 PM MST

  P41. Predictors of manufacturing success after tumor tissue procurement for tumor infiltrating lymphocyte cell therapy
  

  Primary Presenter: Luke V. Selby, MD MS FACS FSSO – University of Kansas Medical Center

  Co-Author: Jordan Baker, MS – Department of Biostatistics & Data Science, University of Kansas Medical Center

  Co-Author: Prabhakar Chalise, PhD – Department of Biostatistics & Data Science, University of Kansas Medical Center

  Co-Author: Matthew C. Perez, MD – Moffitt Cancer Center

  Co-Author: Martin D. McCarter, MD – Department of Surgery, University of Colorado Anschutz Medical Campus

  Co-Author: David Moskal, MD – Department of Surgery, University of Colorado Anschutz Medical Campus

  Co-Author: Kelly Olino, MD (she/her/hers) – Department of Surgery, Yale University

  Co-Author: Gabriela R. Esnaola, BA – Department of Surgery, Yale University

  Co-Author: Jeffrey E. Johnson, M.D. – Department of Surgery, Mayo Clinic

  Co-Author: Jessica Crystal, MD – Department of Surgery, University of Miami Miller School of Medicine

  Co-Author: Ashley M. Holder, MD (she/her/hers) – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center

  Co-Author: Alexandra C. Istl, MD, MPH, FRCSC, FSSO (she/her/hers) – (1) Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin and 2) MCW Cancer Center,

  Co-Author: Edmund Bartlett, M.D., PhD – Memorial Sloan Kettering

  Co-Author: Sonia Cohen, MD, PhD (she/her/hers) – Massachusetts General Hospital

  Co-Author: Joal D. Beane, MD – Department of Surgery, The Ohio State University Wexner Medical Center

  Co-Author: Myles J. Smith, MB BCh BAO, PhD, FRCSI, FRCS – Department of Surgery, The Royal Marsden Hospital and Institute of Cancer Research

  Co-Author: Amanda R. Kirane, MD PhD (she/her/hers) – Stanford University

  Co-Author: Sarah B. Bateni, MD – University of Alabama at Birmingham

  Co-Author: Cristina O'Donoghue, MD, MPH (she/her/hers) – University of Chicago Pritzker School of Medicine

  Co-Author: Julia Terhune, MD – Department of Surgery, University of Maryland

  Co-Author: Giorgos C. Karakousis, MD (he/him/his) – Department of Surgery, University of Pennsylvania Health System

  Co-Author: Amanda Dann, MD – Department of Surgery, UT Southwestern

  Co-Author: Winan J. van Houdt, MD – Department of Surgery, Netherland Cancer Institute

  Co-Author: John E. Mullinax, MD – Moffitt Cancer Center

  Co-Author: Aubrey C. Swilling, DO, MS – Department of Surgery, University of Kansas Medical Center
• 2:32 PM - 2:39 PM MST

  P42. Missed opportunities for neoadjuvant immunotherapy in Melanoma- Time to change imaging guidelines for newly diagnosed patients?
  

  Primary Author: Laurence E. McCahill, MD (he/him/his) – Western Michigan Homer Stryker MD School of Medicine

  Co-Author: Kent Grosh, M.D. – Western Michigan Homer Stryker M.D. School of Medicine

  Co-Author: Amanda Hunt, M.D. – Western Michigan University Homer Stryker M.D. School of Medicine

  Co-Author: Megan Baxter, B.S. – Western Michigan University Homer Stryker M.D. School of Medicine

  Co-Author: Mason Gonzales, M.D. – Western Michigan University Homer Stryker M.D. School of Medicine

  Co-Author: Christine Schmitt, M.D. – Western Michigan University Homer Stryker M.D. School of Medicine

  Co-Author: Kara Anderson, M.D. – Western Michigan University Homer Stryker M.D. School of Medicine

  Co-Author: Theresa McGoff, MBA, BSN – Western Michigan University Homer Stryker M.D. School of Medicine

  Co-Author: Austin Brubaker, B.S. – Western Michigan University Homer Stryker M.D. School of Medicine

  Primary Presenter: Laurence E. McCahill, MD (he/him/his) – Western Michigan Homer Stryker MD School of Medicine
• 2:39 PM - 2:46 PM MST

  P43. Does Sentinel Node Biopsy Reduce the Risk of Death from Melanoma? A Systematic Review and Meta-analysis.
  

  Co-Author: Marie Brinch-Møller Weitemeyer, MD, PhD-candidate – Department of Plastic Surgery, Copenhagen University Hospital - Herlev and Gentofte, Herlev

  Co-Author: Caroline A. Gjorup, MD, PhD, FEBOPRAS – Department of Plastic Surgery, Copenhagen University Hospital

  Co-Author: Serigne N. Lo, PhD – Melanoma Institute Australia, University of Sydney

  Co-Author: Gabrielle J. WIlliams, BSc (Hons), MPH, PhD – Melanoma Institute Australia, University of Sydney

  Co-Author: John F. Thompson, MD, FRACS, FACS (he/him/his) – Melanoma Institute Australia, University of Sydney, Royal Prince Alfred Hospital

  Primary Presenter: Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital
• 2:46 PM - 2:53 PM MST

  P44. Surgical and Clinical Determinants of Lifileucel Manufacturing Success in Adoptive Cell Therapy for Advanced Melanoma
  

  Co-Author: Abigail Fong, MD – City of Hope Comprehensive Cancer Center

  Co-Author: Krupal Patel, MD – City of Hope Comprehensive Cancer Center

  Co-Author: Bradford J. Kim, MD – City of Hope

  Co-Author: Parisa Malekzadeh, MD – City of Hope

  Co-Author: Matthew Hedberg, MD PhD – City of Hope Comprehensive Cancer Center

  Co-Author: Yan Xing, MD – City of Hope Comprehensive Cancer Center

  Co-Author: Hans F. Schoellhammer, MD – City of Hope Comprehensive Cancer Center

  Co-Author: Laleh Melstrom, MD – Department of Surgery, City of Hope National Medical Center, Duarte, CA

  Co-Author: Vijay Trisal, MD (he/him/his) – City of Hope

  Co-Author: Kelly M. Mahuron, MD (she/her/hers) – City of Hope

  Primary Presenter: Daniel Hoffman, MD – City of Hope
• 2:53 PM - 3:00 PM MST

  P45. The management of mucosal melanoma: a population-based analysis of treatment patterns and outcomes
  

  Primary Author: Catherine Sarre, MD, MSc, MHA (she/her/hers) – Western University

  Co-Author: Ashley Drohan, MD, MSc – Dalhousie University

  Co-Author: Ramy Behman, MD, PhD – University of Texas MD Anderson Cancer Center

  Co-Author: Ning Liu, PhD – ICES

  Co-Author: Sho Podolsky, MSc – ICES

  Co-Author: Lilian Gien, MD, MSc – Sunnybrook Health Sciences Centre

  Co-Author: Antoine Eskander, MD, ScM, FRCSC – Sunnybrook Health Sciences Centre, Department of Otolaryngology

  Co-Author: Frances C. Wright, MD Med FRCSC – Sunnybrook Health Sciences Centre

  Co-Author: Nicole J. Look Hong, MD, MSc – Sunnybrook Health Sciences Centre

  Primary Presenter: Catherine Sarre, MD, MSc, MHA (she/her/hers) – Western University
• 3:00 PM - 3:07 PM MST

  P46. Percutaneous versus isolated hepatic perfusion for metastatic uveal melanoma: a propensity score-matched analysis
  

  Primary Presenter: Michelle M. Dugan, MD – University of Florida

  Co-Author: Michelle M. Dugan, MD – University of Florida

  Co-Author: Caitlyn N. Balsay-Patel, MD – Moffitt Cancer Center

  Co-Author: Andrew Wong, MD (he/him/his) – University of Gothenburg

  Co-Author: Wenyi Fan, MSPH – Moffitt Cancer Center

  Co-Author: Younchul Kim, PhD – Moffitt Cancer Center

  Co-Author: Altan Ahmed, MD – Moffitt Cancer Center

  Co-Author: Roger Olofsson Bagge, MD, PhD – University of Gothenburg

  Primary Author: Jonathan S. Zager, MD, FACS – Moffitt Cancer Center

  Co-Author: Anna Stoshak, PA-C – Moffitt Cancer Center
• 3:07 PM - 3:14 PM MST

  P47. Outcomes of Percutaneous Hepatic Perfusion with Melphalan for Metastatic Uveal Melanoma to the Liver: Post FDA Approval Real World Data
  

  Primary Author: Lacey Mead, DO, MS – Moffitt Cancer Center

  Co-Author: Parker Olive, BS – University of South Florida

  Co-Author: Alexis Hernandez-Flores, BS – University of South Florida Morsani College of Medicine

  Co-Author: Caitlyn N. Balsay-Patel, MD – Moffitt Cancer Center

  Co-Author: Michelle M. Dugan, MD – University of Florida

  Co-Author: Altan Ahmed, MD – Moffitt Cancer Center

  Co-Author: Junsung Choi, MD – Moffitt Cancer Center

  Co-Author: Zeynep Eroglu, MD – Moffitt Cancer Center

  Co-Author: Joseph Markowitz, MD, PhD – Moffitt Cancer Center

  Co-Author: Nikhil Khushalani, MD – Moffitt Cancer Center

  Co-Author: Ahmad Tarhini, MD, PhD – Moffitt Cancer Center

  Co-Author: Lilit Karapetyan, MD, MS – Moffitt Cancer Center

  Co-Author: Matthew C. Perez, MD – Moffitt Cancer Center

  Primary Author: Mohammed Alomar, MD – Moffitt Cancer Center, Universtiy of South Florida

  Primary Author: Jonathan S. Zager, MD, FACS – Moffitt Cancer Center

  Co-Author: Anna Stoshak, PA-C – Moffitt Cancer Center

  Primary Presenter: Lacey Mead, DO, MS – Moffitt Cancer Center
• 3:14 PM - 3:21 PM MST

  P48. Duration of adjuvant immunotherapy in sentinel node positive melanoma: How important is completing a full year?
  

  Co-Author: Joshua S. Richman, MD, PhD – University of Alabama at Birmingham

  Co-Author: Tiffany Libtow, MS – University of Michigan

  Co-Author: Tasha M. Hughes, MD, FACS (she/her/hers) – University of Michigan

  Co-Author: Christina V. Angeles, MD, FACS, FSSO (she/her/hers) – University of Michigan

  Co-Author: Michelle M. Dugan, MD – University of Florida

  Co-Author: Caitlyn N. Balsay-Patel, MD – Moffitt Cancer Center

  Co-Author: Jonathan S. Zager, MD, FACS – Moffitt Cancer Center

  Co-Author: Alexander C.J van Akkooi, MD, PhD, MSc, FRACS (he/him/his) – Melanoma Institute of Australia

  Co-Author: Robyn Saw, MBBS, MS, FRACS – Melanoma Institute of Australia

  Co-Author: Alexander Menzies, MBBS, PhD, FRACP – Melanoma Institute of Australia

  Co-Author: Georgina V. Long, AO, MBBS, PhD, MBBS, FRACP – Melanoma Institute of Australia

  Co-Author: Ian Garbarine, MD (he/him/his) – Ohio State University

  Co-Author: Erin E. Burke, MD, MS, FACS – The Ohio State University

  Co-Author: Jan Mattsson, MD, PhD – University of Gothenburg

  Co-Author: Anne Huibers, MD, PhD – University of Gothenburg

  Co-Author: Lisa Kottschade, APRN, CNP – Mayo Clinic -Rochester

  Co-Author: Tina J. Hieken, MD, FACS – Mayo Clinic -Rochester

  Co-Author: Gary C. Doolittle, MD – University of Kansas Medical Center

  Co-Author: Luke V. Selby, MD MS FACS FSSO – University of Kansas Medical Center

  Co-Author: Conor Donnelly, MD (he/him/his) – NYU Langone Health

  Co-Author: Ann Y. Lee, MD, FACS (she/her/hers) – NYU Langone Health

  Co-Author: Gray Peery, BS – University of North Carolina

  Co-Author: David W. Ollila, MD, FACS (he/him/his) – University of North Carolina School of Medicine

  Co-Author: Kaiya Kozuma, BS – Oregon Health & Science University

  Co-Author: John T. Vetto, MD, FACS, FSSO – Oregon Health & Science University

  Co-Author: Hannah G. McDonald, MD – University of Kentucky

  Co-Author: Leah K. Winer, MD – University of Kentucky

  Co-Author: Chelsea R. Olson, MD – The University of Tennessee Health Science Center

  Co-Author: Martin D. Fleming, MD, FACS (he/him/his) – University of Tennessee Health Science Center

  Co-Author: Julia Geaghan-Breiner, BS – University of Vermont

  Co-Author: Jessica A. Cintolo-Gonzalez, MD, FACS – University of Vermont

  Co-Author: Margaret O'Connor, MD, PhD – Duke University

  Co-Author: Georgia M. Beasley, MD, MHSc, FACS (she/her/hers) – Duke University

  Co-Author: Bethel Ozed-Williams, MD – University of Minnesota

  Co-Author: Jane Yuet Ching Hui, MD, MS, FACS – University of Minnesota

  Co-Author: Jennifer Hwang, MD – Fox Chase Cancer Center

  Co-Author: Jeffrey M. Farma, MD, FACS (he/him/his) – Fox Chase Cancer Center

  Co-Author: Kristy K. Broman, MD, MPH, FACS (she/her/hers) – University of Texas MD Anderson Cancer Center

  Primary Presenter: Nicole Rademacher, MD (she/her/hers) – University of Alabama at Birmingham